Zhen-Ling Li1 article listing Zhen-Ling Li in Nature Communications, indexed by Paperzzz from Crossref and OSF.Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial Nature Communications